IP 253 Pill - orange round, 9mm
Pill with imprint IP 253 is Orange, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Amneal Pharmaceuticals.
Ranitidine is used in the treatment of GERD; Gastric Ulcer Maintenance Treatment; Erosive Esophagitis; Cutaneous Mastocytosis; Duodenal Ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IP 253
Ranitidine Hydrochloride
- Imprint
- IP 253
- Strength
- 150 mg
- Color
- Orange
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 53746-0253 (Discontinued) | Amneal Pharmaceuticals LLC |
| 65162-0253 (Discontinued) | Amneal Pharmaceuticals LLC |
| 63739-0489 (Discontinued) | McKesson Packaging Services |
| 68084-0717 (Discontinued) | Amerisource Health Services |
| 42291-0724 (Discontinued) | AvKare, Inc. |
| 66267-0188 (Discontinued) | Nucare Pharmaceuticals Inc. (repackager) |
| 68071-1321 | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "IP 253"
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.